In the rapidly evolving age of artificial intelligence, scientists are using it to expedite drug development, uncovering treatments for neurological conditions that may be hiding in plain sight.

However, researchers at the UK Dementia Research Institute in Edinburgh analyze patient data-including voice recordings and eye scans to determine whether existing drugs could be therapeutic switching such as motor neurone disease (MND). 

Steve Barrett, a trial participant living with MND 10 years ago shared his vision for the project's success.

MND is a horrible........

© The News International